Severity
Not classified by agency
No agency classActive
CPSC recall · Reported May 15, 2019
Hush Recalls Anesthetic Gels, Sprays and Foam Soaps Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The products contain lidocaine, posing a risk of poisoning to young children if they put t…
A.i.g. Technologies, Inc. of Deerfield Beach, Fla.. recalled This recall involves Hush gel, spray and foam soap products containing 4% lidocaine. The ….
Hush Recalls Anesthetic Gels, Sprays and Foam Soaps Due to Failure to Meet Child Resistan… was recalled by A.i.g. Technologies, Inc. of Deerfield Beach, Fla.. in May 15, 2019. Reason: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The products contain…. Remedy: Consumers should immediately place the recalled products out of the reach of children and…. Verify recall #19120 with the CPSC before acting.
The recall
A.i.g. Technologies, Inc. of Deerfield Beach, Fla.. issued this CPSC recall-The packaging is not child resistant as required by the Poison Prevention Packaging Act. The products contain….
- None
- agency class
- May 15, 2019
- reported
Sourced from official CPSC enforcement records. Verify recall #19120 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This CPSC action (record #19120) was formally reported on May 15, 2019. The CPSC does not publish a hazard classification for its recalls, so this record carries no agency severity grade, with a current status of Active. A.i.g. Technologies, Inc. of Deerfield Beach, Fla.. is listed as the recalling firm. Federal records list the affected scope as About 275,000.
The documented reason for this recall is: The packaging is not child resistant as required by the Poison Prevention Packaging Act. The products contain lidocaine, posing a risk of poisoning to young children if they put the product on their skin or ingest it. Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately place the recalled products out of the reach of children and contact Hush for a full refund, a free replacement cream or free replacement child-resistant cap. - consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Drugs & Medications recalls over time
Where this recall sits in its category - 14,436 drugs & medications recalls on record
Affected scope
About 275,000
Related Recalls
6
0 from same agency
Product description
This recall involves Hush gel, spray and foam soap products containing 4% lidocaine. The gel and spray were sold in 2 and 4-ounce sizes and the foam soap was sold in 1.7-ounce size. The bottles are white or black and have printed in green at the front the Hush logo or the phrase Hush and the type of product. The Drug Facts label is on the back. The lot number and expiration date are stamped on the bottom of the container. All lot numbers included in the recall.
Reason for recall
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The products contain lidocaine, posing a risk of poisoning to young children if they put the product on their skin or ingest it.
Remedy, what to do
Consumers should immediately place the recalled products out of the reach of children and contact Hush for a full refund, a free replacement cream or free replacement child-resistant cap.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Not classified by agency |
| Status | Active |
| Recall number | 19120 |
| Date reported | May 15, 2019 |
| Date initiated | May 15, 2019 |
| Recalling firm | A.i.g. Technologies, Inc. of Deerfield Beach, Fla.. |
| Affected scope | About 275,000 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately place the recalled products out of the reach of children and contact Hush for a full refund, a free …
- Check the recall number (19120) and product description against the item you own. Search the archive
- Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
This recall involves Hush gel, spray and foam soap products containing 4% lidocaine. The gel and spray were sold in 2 and 4-ounce sizes and the foam soap was sold in 1.7-ounce size. The bottles are white or black and have printed in green at the front the Hush logo or the phrase Hush and the type of product. The Drug Facts label is on the back. The lot number and expiration date are stamped on the bottom of the container. All lot numbers included in the recall.. Recalled by A.i.g. Technologies, Inc. of Deerfield Beach, Fla... Units affected: About 275,000.
Why was this product recalled? ▼
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The products contain lidocaine, posing a risk of poisoning to young children if they put the product on their skin or ingest it.
What should consumers do? ▼
Consumers should immediately place the recalled products out of the reach of children and contact Hush for a full refund, a free replacement cream or free replacement child-resistant cap.
Which agency issued this recall? ▼
This recall was issued by the CPSC on May 15, 2019. CPSC does not publish a hazard classification for this recall. Recall number: 19120.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (19120) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product? ▼
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.
Nationwide recalls with similar severity or category timing
Two federal-filing-derived peer sets for this notice, both outside the same recalling firm and filing state so the neighborhoods are not firm or geographic containment.
Similar severity · nearest report date
Same archive severity grade, closest by report date among other firms and states.
Similar Drugs & Medications · nearest report date
Same product category, closest by report date among other firms and states (deduped against the severity set).
Nearby Recalls in This Category
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Showing 5 of 14436 other recalls in this category.
FDA Drug Moderate
Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Sterile 0.4 FL OZ (13 mL)…
Rohto-Mentholatum (Vietnam) Co., Ltd. · 2026-07-29
FDA Drug Moderate
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packa…
Major Pharmaceuticals · 2026-07-29
FDA Drug Moderate
Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polysorbate 80 0.2%), Sterile, 0.4 FL OZ (13 mL)…
Rohto-Mentholatum (Vietnam) Co., Ltd. · 2026-07-29
FDA Drug Moderate
Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Pac…
Major Pharmaceuticals · 2026-07-29
FDA Drug Moderate
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Pac…
Major Pharmaceuticals · 2026-07-29
Compare this recall with Rohto Cooling Eye Drops Max Strength (naphazoline hydrochlo… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported May 15, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.